دورية أكاديمية
Analysis of Immunobiological Properties of Recombinant Streptococcus pneumoniae Pneumolysin.
| العنوان: | Analysis of Immunobiological Properties of Recombinant Streptococcus pneumoniae Pneumolysin. |
|---|---|
| المؤلفون: | Vorobyev DS; I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia. vorobievdenis@yandex.ru., Petukhova ES; I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia., Volokh YV; I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia., Semenova IB; I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia. |
| المصدر: | Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Country of Publication: United States NLM ID: 0372557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-8221 (Electronic) Linking ISSN: 00074888 NLM ISO Abbreviation: Bull Exp Biol Med Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York : Springer Original Publication: New York, Consultants Bureau. |
| مستخلص: | We compared the immunogenicity of recombinant S. pneumoniae pneumolysin (rPly) when administered with and without Al(OH) (© 2024. Springer Science+Business Media, LLC, part of Springer Nature.) |
| References: | Briko NI, Korshunov VA, Lomonosov KS. Pneumococcal infection in Russia: state of the issue. Vestn. Ross. Akad. Med. Nauk. 2021;76(1):28-42. Russian. https://doi.org/10.15690/vramn1404. Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia (Nathan). 2022;14(1):5. https://doi.org/10.1186/s41479-022-00097-y. (PMID: 10.1186/s41479-022-00097-y361536369509586) Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat. Rev. Microbiol. 2018;16(6):355-367. https://doi.org/10.1038/s41579-018-0001-8. (PMID: 10.1038/s41579-018-0001-8295994575949087) Izu A, Solomon F, Nzenze SA, Mudau A, Zell E, O’Brien KL, Whitney CG, Verani J, Groome M, Madhi SA. Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. Bull. World Health Organ. 2017;95(9):618-628. https://doi.org/10.2471/BLT.16.187849. (PMID: 10.2471/BLT.16.187849288678425578378) Masomian M, Ahmad Z, Gew LT, Poh CL. Development of next generation Streptococcus pneumoniae vaccines conferring broad protection. Vaccines (Basel). 2020;8(1):132. https://doi.org/10.3390/vaccines8010132. (PMID: 10.3390/vaccines8010132321921177157650) Scott NR, Mann B, Tuomanen EI, Orihuela CJ. Multi-valent protein hybrid pneumococcal vaccines: a strategy for the next generation of vaccines. Vaccines (Basel). 2021;9(3):209. https://doi.org/10.3390/vaccines9030209. (PMID: 10.3390/vaccines9030209338013728002124) Converso TR, Assoni L, André GO, Darrieux M, Leite LCC. The long search for a serotype independent pneumococcal vaccine. Expert Rev. Vaccines. 2020;19(1):57-70. https://doi.org/10.1080/14760584.2020.1711055. (PMID: 10.1080/14760584.2020.171105531903805) Micoli F, Romano MR, Carboni F, Adamo R, Berti F. Strengths and weaknesses of pneumococcal conjugate vaccines. Glycoconj J. 2023;40(2):135-148. https://doi.org/10.1007/s10719-023-10100-3. (PMID: 10.1007/s10719-023-10100-33665205110027807) Soubal JP, PeñaL, Santana D, Valdés Y, García D, Pedroso J, Cardoso F, González H, Fernández V, Vérez V. Procedure for the conjugation of the Streptococcus pneumoniae serotype 6B capsular polysaccharide to the tetanus toxoid. Biotecnol. Apl. 2013;30(3):208-215. Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal vaccines. Microbiol. Spectr. 2019;7(6). https://doi.org/10.1128/microbiolspec.GPP3-0028-2018. Aceil J, Avci FY. Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets. Front. Cell Infect. Microbiol. 2022;12:832254. https://doi.org/10.3389/fcimb.2022.832254. (PMID: 10.3389/fcimb.2022.832254356467479133333) Nishimoto AT, Rosch JW, Tuomanen EI. Pneumolysin: pathogenesis and therapeutic target. Front. Microbiol. 2020;11:1543. https://doi.org/10.3389/fmicb.2020.01543. (PMID: 10.3389/fmicb.2020.01543327143147343714) Vorobyev DS, Sidorov AV, Kaloshin AA, Mikhailova NA, Poddubikov AV, Gruber IM. Preparation a recombinant form of pneumolysin protein from Streptococcus pneumoniae. Bull. Exp. Biol. Med. 2023;174(6):749-753. https://doi.org/10.1007/s10517-023-05785-3. (PMID: 10.1007/s10517-023-05785-337160796) Vaneeva NP, Yastrebova NE. Specific immune response to certain capsule polysaccharides of Streptococcus pneumoniae in healthy blood donors and individuals immunized with pneumococcal vaccines. Zh. Mikrobiol. Epidemiol. Immunobiol. 2015;(5):20-26. Russian. Petukhova ES, Vorobyev DS, Sidorov AV, Semenova IB, Volokh YV, Leonova AY, Sidorova AV, Mikhailova NA. Immunization with recombinant pneumolysin induces the production of antibodies and protects mice in a model of systemic infection caused by Streptococcus pneumoniae. Bull. Exp. Biol. Med. 2020;168(4):485-487. https://doi.org/10.1007/s10517-020-04736-6. (PMID: 10.1007/s10517-020-04736-632146631) Tokarskaya MM, Nayanova EA, Nechaeva OV, Baranovskaya SA, Afanacyeva OM, Vorobyev DS, Gruber IM, Astashkina EA, Ovechko NN, Semenova IB, Yastrebova NE. Immunobiological properties of antigenic preparations Streptococcus pneumoniae and their mixtures. Epidemiol. Vaktsinoprof. 2021;20(6):5-11. Russian. https://doi.org/10.31631/2073-3046-2021-20-6-5-11. |
| فهرسة مساهمة: | Keywords: Streptococcus pneumoniae; aluminum hydroxide; antibody level; protective activity; recombinant pneumolysin |
| تواريخ الأحداث: | Date Created: 20240801 Latest Revision: 20240801 |
| رمز التحديث: | 20240802 |
| DOI: | 10.1007/s10517-024-06166-0 |
| PMID: | 39090461 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!